P3 Health Partners(NASDAQ) PIIIW

Market CapN/A

Since IPO (2021)-98%

5 Year-99%

1 Year+4%

1 Month-39%

$0.01

-23.73%

-0.00Today

P3 Health Partners last closing stock price
Metric	Price	Date
Last close	USD 0.01	2026-09-09

P3 Health Partners stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-4.84%	USD 0.01	2026-09-02
1 month	-39.49%	USD 0.02	2026-08-10
3 month	-29.76%	USD 0.02	2026-06-11
Year to date	+18%	USD 0.01	2025-12-31
1 year	+3.51%	USD 0.01	2025-09-09
3 year	-95.28%	USD 0.25	2023-09-08
5 year	-98.9%	USD 1.07	2021-09-10
Since inception	-98.43%	USD 0.75	2021-04-07

P3 Health Partners Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$1.50B

Net Income (TTM)

-$98.44M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.22 (Low)

Dividend

$0.00

Beta (Volatility)

0.22 (Low)

Price

$0.01

Volume

4,332

Open

$0.01

Price

$0.01

Volume

4,332

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.00 - $0.25

Estimated Earnings Date

Nov 18, 2026

Dividend

$0.00

Beta (Volatility)

0.22 (Low)

Price

$0.01

Volume

4,332

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.00 - $0.25

Estimated Earnings Date

Nov 18, 2026

PIIIW News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About P3 Health Partners

P3 Health Partners Inc. is a patient-centered and physician-led population health management company that provides superior care services across the United States. Founded in 2020 and based in Henderson, Nevada, the company operates clinics and wellness centers aimed at improving patient outcomes.

Products and Services

Comprehensive population health management solutions
Patient-centered care through clinics and wellness centers
Data-driven strategies to enhance healthcare delivery

Growth Outlook

Revenue of $386.4 million reported in Q2 2026, indicating stability
Operating income of $41.2 million in Q2 2026, showcasing operational efficiency
Strong gross profit margin of 22.2% in Q2 2026, reflecting effective cost management

Financial Highlights

Net income of $7.4 million in Q2 2026, a positive shift from previous quarters
Cash and cash equivalents of $21.3 million as of June 30, 2026, ensuring liquidity
Debt ratio of 19.9%, indicating manageable leverage levels

P3 Health Partners Inc. has demonstrated a commitment to enhancing healthcare delivery through innovative solutions. The recent financial performance reflects a positive trajectory, with significant revenue and net income growth. The company's focus on patient-centered care and operational efficiency positions it well for future expansion in the healthcare sector. With a solid foundation and strategic growth initiatives, P3 Health Partners Inc. is poised to make a meaningful impact in the healthcare landscape.

AI Generated • Sep 3, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Headquarters

Henderson, NV 89074, US

PIIIW Financials

Key Financial Metrics (TTM)

Gross Margin

31.65%

Operating Margin

-9.89%

Net Income Margin

-6.55%

Return on Equity

160.54%

Return on Capital

-208.48%

Return on Assets

-15.04%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

Volume

4.33K

Avg. Volume

99.27K

Financials (TTM)

Gross Profit

$475.57M

Operating Income

-$148.63M

EBITDA

-$82.31M

Operating Cash Flow

-$130.52M

Capital Expenditure

$0.00

Free Cash Flow

-$130.40M

Cash & ST Invst.

$21.27M

Total Debt

$130.27M

P3 Health Partners Performance Analysis

P3 Health Partners sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-30	-3.0%
Q4	2025-12-31	11.5%
Q1	2026-03-31	0.4%
Q2	2026-06-30	-0.0%

P3 Health Partners sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-30	-55.2%
Q4	2025-12-31	-138.1%
Q1	2026-03-31	101.6%
Q2	2026-06-30	-270.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$386.38M

+8.6%

Gross Profit

$86.00M

-75.8%

Gross Margin

22.26%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

320

N/A

Net Income

$7.44M

+136.6%

EBITDA

$45.82M

+538.2%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

$21.27M

-44.9%

Total Debt

$130.27M

-32.4%

Accounts Receivable

$135.27M

+33.9%

Inventory

$0.00

N/A

Long Term Debt

$108.47M

-3.4%

Short Term Debt

$21.80M

-72.9%

Return on Assets

-15.04%

N/A

Return on Invested Capital

-55.91%

N/A

Free Cash Flow

-$61.91M

-272.2%

Operating Cash Flow

-$61.91M

-272.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ACONAclarion, Inc.

ACONAclarion, Inc.$2.51+3.71%

VINCVincerx Pharma, Inc.

VINCVincerx Pharma, Inc.$0.02+7400.00%

VRPXVirpax Pharmaceuticals, Inc.

VRPXVirpax Pharmaceuticals, Inc.$0.00+0.00%

FOXOFOXO Technologies Inc.

FOXOFOXO Technologies Inc.$0.10+0.00%

REVBRevelation Biosciences, Inc.

REVBRevelation Biosciences, Inc.$1.00-0.99%

SLXNWSilexion Therapeutics Ltd.

SLXNWSilexion Therapeutics Ltd.$0.01-14.29%

DRMADermata Therapeutics, Inc.

DRMADermata Therapeutics, Inc.$1.23+1.24%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$150.03+0.02%

INTCIntel

INTCIntel$100.97-0.05%

NVDANvidia

NVDANvidia$218.28-0.02%

SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF

SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF$45.88+0.06%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$70.02-0.02%

SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF

SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF$118.21-0.06%

CIFRCipher Digital

CIFRCipher Digital$16.38-0.03%

Questions About PIIIW

What is the current price of P3 Health Partners?

P3 Health Partners is trading at $0.01 per share.

What is the 52-week range for P3 Health Partners?

Over the past 52 weeks, P3 Health Partners has traded between $0.00 and $0.25.

How much debt does P3 Health Partners have?

P3 Health Partners total debt is unavailable.

How much cash does P3 Health Partners have on hand?

P3 Health Partners does not have cash on hand data available.

What is P3 Health Partners’s dividend yield?

P3 Health Partners does not currently have a dividend yield.

P3 Health Partners(NASDAQ) PIIIW

P3 Health Partners Financials at a Glance

PIIIW News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About P3 Health Partners

PIIIW Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

P3 Health Partners Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PIIIW

What is the current price of P3 Health Partners?

What is the 52-week range for P3 Health Partners?

How much debt does P3 Health Partners have?

How much cash does P3 Health Partners have on hand?

What is P3 Health Partners’s dividend yield?

Premium Investing Services